Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Pinturaud

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|January 29, 2019
Marine Pinturaud, Michèle Vasseur, Pascal Odou
Occupational and Environmental Medicine|December 4, 2024
Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacyLaure Deramoudt, Marine Pinturaud, Peggy Bouquet, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 26, 2024
Assessment of chemical contamination by cancer drugs during use of the RIVA<sup>TM</sup> compounding robot: A pilot studyMyriam Bouchfaa, Michèle Vasseur, Justin Courtin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2020
Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unitOphélie Petit, Guillaume Saint-Lorant, Michèle Vasseur, et al.
Cytotherapy|May 12, 2025
The pharmaceutical circuit of Advanced Therapy Medicinal Products-guidelines of the French Society for Oncology PharmacyBertrand Pourroy, Isabelle Madelaine, Muriel Carvalho, et al.
Plos One|July 9, 2016
Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel StudyNicolas Simon, Michèle Vasseur, Marine Pinturaud, et al.
Bulletin Du Cancer|September 25, 2019
[Requirements for academic production of CAR-T cells in accordance with Good Pharmaceutical Practice (GMP). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Marina Deschamps, Véronique Decot, Camille Giverne, et al.
Bulletin Du Cancer|November 28, 2017
[Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Ibrahim Yakoub-Agha, Christophe Ferrand, Yves Chalandon, et al.
Hematological Oncology|October 23, 2025
The French Experience of Pharmacists and CAR T-Cells: A Study of the French Society of Oncology Pharmacy (SFPO)Vérane Schwiertz, Romain de Jorna, Adeline Quintard, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|January 29, 2019
Marine Pinturaud, Michèle Vasseur, Pascal Odou
Occupational and Environmental Medicine|December 4, 2024
Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacyLaure Deramoudt, Marine Pinturaud, Peggy Bouquet, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 26, 2024
Assessment of chemical contamination by cancer drugs during use of the RIVA<sup>TM</sup> compounding robot: A pilot studyMyriam Bouchfaa, Michèle Vasseur, Justin Courtin, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2020
Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unitOphélie Petit, Guillaume Saint-Lorant, Michèle Vasseur, et al.
Cytotherapy|May 12, 2025
The pharmaceutical circuit of Advanced Therapy Medicinal Products-guidelines of the French Society for Oncology PharmacyBertrand Pourroy, Isabelle Madelaine, Muriel Carvalho, et al.
Plos One|July 9, 2016
Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel StudyNicolas Simon, Michèle Vasseur, Marine Pinturaud, et al.
Bulletin Du Cancer|September 25, 2019
[Requirements for academic production of CAR-T cells in accordance with Good Pharmaceutical Practice (GMP). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Marina Deschamps, Véronique Decot, Camille Giverne, et al.
Bulletin Du Cancer|November 28, 2017
[Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Ibrahim Yakoub-Agha, Christophe Ferrand, Yves Chalandon, et al.
Hematological Oncology|October 23, 2025
The French Experience of Pharmacists and CAR T-Cells: A Study of the French Society of Oncology Pharmacy (SFPO)Vérane Schwiertz, Romain de Jorna, Adeline Quintard, et al.
Pageof 1